Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Share News (MCS)

  • There is currently no data for MCS

Wednesday broker round-up

Wed, 15th Jul 2020 12:24
(Sharecast News) - Royal Dutch Shell: JP Morgan downgrades to neutral with a target price of 1,700.0p.



Ocado Group: Berenberg reiterates buy with a target price of 2,225.0p.

DFS: Berenberg reiterates buy with a target price of 210.0p.

Atalaya Mining: Canaccord reiterates buy with a target price of 220.0p.

McCarthy & Stone: Canaccord reiterates hold with a target price of 82.0p.

Ferrexpo: JP Morgan downgrades to underweight with a target price of 150.0p.

GlaxoSmithKline: Citigroup reiterates neutral.

Auto Trader Group: Deutsche Bank reiterates buy with a target price of 680.0p.

London Stock Exchange: Deutsche Bank reiterates hold with a target price of 7,700.0p.

Legal & General Group: Deutsche Bank reiterates buy with a target price of 290.0p.

Senior: Barclays reiterates underweight with a target price of 45.0p.

Marks & Spencer Group: Barclays reiterates overweight with a target price of 140.0p.

Fevertree Drinks: Liberum reiterates buy with a target price of 2,570.0p.

Big Yellow Group: Liberum reiterates hold with a target price of 1,000.0p.

Dunelm Group: Peel Hunt reiterates buy with a target price of 1,400.0p.

Related News

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial
56 mins ago

GSK, Hansoh's targeted cancer drug hits main survival goal in China trial

* GSK partner Hansoh reports first late-stage data ​for experimental ⁠lung cancer drug

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial
2 hours ago

GSK says Ris-Rez meets primary endpoint in phase 3 lung cancer trial

(Alliance News) - GSK PLC on Friday announced that risvutatug rezetecan has delivered "meaningful" survival data in a "pivotal" trial for advanced or ...

GSK hails 'milestone' drug trial results in China
3 hours ago

GSK hails 'milestone' drug trial results in China

(Sharecast News) - A targeted lung cancer treatment developed by GSK has shown promising results in the latest trials in China, the pharma blue chip c...

MCS.L News

UK Shareholder Meetings Calendar - Next 7 Days
30 Nov 2020

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Hammerson, McCarthy & Stone Could Rejoin FTSE 250 In Upcoming Review
25 Nov 2020

Hammerson, McCarthy & Stone Could Rejoin FTSE 250 In Upcoming Review

Hammerson, McCarthy & Stone Could Rejoin FTSE 250 In Upcoming Review

Wednesday broker round-up
11 Nov 2020

Wednesday broker round-up

(Sharecast News) - easyJet: Bank of America Merrill Lynch upgrades to buy.

McCarthy & Stone Annual Loss In Line With Internal Expectations
11 Nov 2020

McCarthy & Stone Annual Loss In Line With Internal Expectations

McCarthy & Stone Annual Loss In Line With Internal Expectations

McCarthy & Stone completions, sales drop due to Covid-19
11 Nov 2020

McCarthy & Stone completions, sales drop due to Covid-19

(Sharecast News) - Retirement housebuilder McCarthy & Stone said on Wednesday that it was on course for a full-year underlying loss in line with i...

UK BROKER RATINGS SUMMARY: Goldman Sachs And BofA Both Lift IAG To Buy
11 Nov 2020

UK BROKER RATINGS SUMMARY: Goldman Sachs And BofA Both Lift IAG To Buy

UK BROKER RATINGS SUMMARY: Goldman Sachs And BofA Both Lift IAG To Buy

UK Earnings, Trading Statements Calendar - Next 7 Days
4 Nov 2020

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

UK BROKER RATINGS SUMMARY: Analysts Positive On The Hut Group
27 Oct 2020

UK BROKER RATINGS SUMMARY: Analysts Positive On The Hut Group

UK BROKER RATINGS SUMMARY: Analysts Positive On The Hut Group